Background: Individuals diagnosed with diabetes mellitus have an increased risk of cardiovascular disease, often leading to premature morbidity and mortality. As the number of youth developing T1D and T2D continues to grow, early onset predisposes patients to a longer burden of disease and earlier onset of cardiovascular complications. Early identification and effective management and treatment of risk factors can lead to decreased cardiovascular events and improved quality of life.
Objective: In this study, we describe the prevalence of CVD risk factors in children with diabetes.
Results: 274 subjects were included in this study, all > 1 year since the time of diagnosis. 134 participants were male (49%). Mean age was 13.7 years (males); 12.8 years (females). subjects averaged 4 diabetes-related visits per year. At the time of their most recent clinic visit, 33% of subjects had a HbA1c < 8%, and 29% had a HbA1c > 10%. Greater than 50% of subjects were overweight or obese. A significant number of subjects were found to have dyslipidemia, and elevated blood pressure was common.
Discussion: CVD risk factors are common in children with diabetes mellitus. Good glycemic control, early identification, and effective life-long management of all CVD risk factors may help decrease the high rate of premature morbidity and mortality in diabetes.
Keywords: Dyslipidemia, cardiovascular disease, youth, diabetes, risk factors, glycemic control.
Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Insulin Resistance and Alzheimers Disease Pathogenesis: Potential Mechanisms and Implications for Treatment
Current Alzheimer Research Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Current Vascular Pharmacology Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews Dissecting Insulin Signaling Pathways: Individualised Therapeutic Targets for Diagnosis and Treatment of Insulin Resistant States
Endocrine, Metabolic & Immune Disorders - Drug Targets Insulin Secreted From Genetically Engineered Intestinal Cells Reduces Blood Glucose Levels in Diabetic Mice
Current Gene Therapy Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Chronic Complications of Diabetes Mellitus: A Mini Review
Current Diabetes Reviews Coffee: A Selected Overview of Beneficial or Harmful Effects on the Cardiovascular System?
Current Vascular Pharmacology Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Pulmonary Complications in Diabetes Mellitus: The Role of Glycemic Control
Current Drug Targets - Inflammation & Allergy MTHFR Gene Polymorphism and Diabetic Retinopathy
Current Diabetes Reviews Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction
Current Pharmaceutical Design CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Cardiac Stem Cell Characteristics in Physiological and Pathological Conditions
Current Pharmaceutical Design Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Current Vascular Pharmacology Neonatal Diabetes: Applying Molecular Biology to Patient Care
Current Pediatric Reviews Involvement of Intracellular pH in Vascular Insulin Resistance
Current Vascular Pharmacology DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus
Current Pharmaceutical Design Heart Failure in the Middle East
Current Cardiology Reviews